FLT3 inhibitors potentially improve response rates in acute myeloid leukemia harboring t(6;9)(DEK::NUP214): the Mayo Clinic experience.
Csizmar CM, Saliba AN, Greipp PT, Alkhateeb H, Begna KH, Foran JM, Gangat N, Hogan WJ, Hook CC, Litzow MR, Mangaonkar AA, Palmer JM, Pardanani A, Shah MV, Tefferi A, Torghabeh MH, Wolanskyj-Spinner AP, Patnaik MM, Kaufmann SH, Al-Kali A.
Csizmar CM, et al. Among authors: wolanskyj spinner ap.
Haematologica. 2024 Nov 1;109(11):3785-3789. doi: 10.3324/haematol.2024.285359.
Haematologica. 2024.
PMID: 38899336
Free PMC article.
No abstract available.